Other specified/unspecified hearing loss

H8_HL_NAS

sensorineural hearing loss: Hearing loss in which the root cause lies in the inner ear or sensory organ (cochlea and associated structures) or the vestibulocochlear nerve (cranial nerve VIII).

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H91.8, H91.9 Hospital discharge: ICD-9 — 389[8-9] Hospital discharge: ICD-8 — 389 Cause of death: ICD-10 — H91.8, H91.9 Cause of death: ICD-9 — 389[8-9] Cause of death: ICD-8 — 389 2 out of 7 registries used, show all original rules.	3264
4. Check minimum number of events None	3264
5. Include endpoints None	3264
6. Filter based on genotype QC (FinnGen only)	3264

Control definitions (FinnGen only)

Control exclude: H8_OTHEREAR

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	H8_HL_NAS
CONTROL_EXCLUDE	H8_OTHEREAR
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H91[8-9]
HD_ICD_9	389[8-9]
HD_ICD_8	389
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H91[8-9]
COD_ICD_9	389[8-9]
COD_ICD_8	389
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other specified/unspecified hearing loss based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	30941	15915	14885
Only index persons	27863	14799	13064
Unadjusted period prevalence (%)
Whole population	0.44	0.46	0.42
Only index persons	0.52	0.54	0.50
Median age at first event (years)
Whole population	68.04	69.82	66.22
Only index persons	68.95	70.43	67.26

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3264	1634	1630
Unadjusted period prevalence (%)	0.64	0.56	0.72
Median age at first event (years)	65.31	61.53	69.09

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2827: Matched controls
28271

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

240.9

323.0

1456

124

DFF00

NOMESCO Finland

Pure tone audiometry

30.6

323.0

789

353

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

65.1

323.0

509

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

126.9

323.0

440

Z01.1

ICD-10 Finland

Examination of ears and hearing

18.7

323.0

1189

1053

H91.9

ICD-10 Finland

Hearing loss, unspecified

791.1

323.0

2344

173

Z97.4

ICD-10 Finland

Presence of external hearing-aid

54.2

323.0

552

126

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

44.5

323.0

686

202

R5120

NOMESCO Finland

Preparation of an aid

53.3

323.0

472

106

DAX08

NOMESCO Finland

Fitting of hearing aid

46.1

264.9

327

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

6.8

258.0

735

1389

DFF15

NOMESCO Finland

Speech audiometry

28.6

255.8

354

141

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

200.8

248.9

256

H91.8

ICD-10 Finland

Other specified hearing loss

76.1

231.9

263

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

44.4

219.5

273

R5140

NOMESCO Finland

Monitoring the use of the aid

6.4

211.8

620

1184

H02

ICPC

Hearing complaint

6.4

209.7

618

1189

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

128.5

200.3

214

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

503.3

191.7

189

H91.1

ICD-10 Finland

Presbycusis

12.2

176.3

334

306

N07CA01

ATC

betahistine; oral

7.2

161.7

425

682

38990

ICD-8 Finland

Other deafness, Partialis uni-sive bilateralis

+∞

157.8

150

H93.1

ICD-10 Finland

Tinnitus

14.1

145.6

257

199

Z3229

NOMESCO Finland

Other healthcare associate professional

5.4

134.5

447

957

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

33.2

118.7

157

UDC00

NOMESCO Finland

Ear microscopy

7.1

116.2

303

471

H61.2

ICD-10 Finland

Impacted cerumen

5.2

85.3

284

595

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

114.8

82.4

H29

ICPC

Ear symptom/complaint other

3.7

81.7

391

1164

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

408.8

80.3

ZXA00

NOMESCO Finland

Right side

2.2

72.4

938

5128

SPAT1043

SPAT

Audiometry

3.8

71.0

330

952

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

128.3

70.2

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

6.7

66.2

176

277

H81.0

ICD-10 Finland

Ménière disease

10.5

63.5

127

126

Z25.1

ICD-10 Finland

Need for immunization against influenza

4.0

62.5

266

708

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

51.3

62.4

H81

ICPC

Excessive ear wax

2.5

61.6

550

2463

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.7

60.9

292

861

ZXA05

NOMESCO Finland

Left side

2.1

59.2

861

4861

DFE00

NOMESCO Finland

Insertion of cochlear implant

+∞

57.5

R42

ICD-10 Finland

Dizziness and giddiness

2.2

56.8

695

3623

R1260

NOMESCO Finland

Evaluation of communicative skills

8.8

56.2

124

147

RK520

NOMESCO Finland

36.1

52.1

DC1AD

NOMESCO Finland

Temporalbone CT

24.6

50.8

Z71.8

ICD-10 Finland

Other specified counselling

2.1

50.0

666

3573

H80.9

ICD-10 Finland

Otosclerosis, unspecified

26.7

49.1

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

14.2

48.7

R4135

NOMESCO Finland

Rehabilitation for hearing problems

32.2

47.8

H13

ICPC

Plugged feeling ear

2.2

47.4

541

2702

H90.5

ICD-10 Finland

Sensorineural hearing loss, unspecified

19.6

45.4

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

36.3

44.5

H80.0

ICD-10 Finland

Otosclerosis involving oval window, nonobliterative

21.8

42.3

DFX00

NOMESCO Finland

Connecting cochlear implant

+∞

41.8

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

2.5

41.1

363

1588

38920

ICD-8 Finland

Other deafness, Deafness, one ear

+∞

40.7

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

17.6

39.4

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.7

39.3

285

1113

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

39.1

519

2747

RK320

NOMESCO Finland

11.0

38.3

TDA90

SPAT

5.8

37.7

110

196

DFF16

NOMESCO Finland

Speech-in-noise audiometry

+∞

36.5

N02BE01

ATC

paracetamol; systemic, rectal

1.8

36.4

2314

20063

SPAT1041

SPAT

Comprehensive hearing test

10.7

36.3

ZXA10

NOMESCO Finland

Bilateral

2.0

35.9

564

3181

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

10.2

35.5

38998

ICD-8 Finland

Other deafness, Alia definita

+∞

35.5

38999

ICD-8 Finland

Other deafness, Impairment of hearing, one or both ears

+∞

34.4

R4110

NOMESCO Finland

Physiotherapy

1.8

34.4

786

5041

M79.6

ICD-10 Finland

Pain in limb

1.7

34.1

925

6244

RK110

NOMESCO Finland

10.1

33.8

3891A

ICD-9 Finland

Deafness, Sensorineural deafness

+∞

33.4

R39.1

ICD-10 Finland

Other difficulties with micturition

4.0

33.4

138

356

H25.1

ICD-10 Finland

Senile nuclear cataract

1.7

33.0

813

5321

WW200

SPAT

2.4

32.7

291

1270

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.1

32.5

400

2035

ZYC01

NOMESCO Finland

Remote contact by phone

3.5

31.9

154

453

R51.80

ICD-10 Finland

Headache

2.2

31.7

365

1805

A02BC02

ATC

pantoprazole; systemic

1.6

31.7

1696

13657

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

10.5

31.6

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

6.8

30.4

118

38900

ICD-8 Finland

Other deafness, Deafness, both ears

+∞

30.3

H28

ICPC

Limited function/disability (H)

10.9

29.7

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

29.6

932

6502

R06.0

ICD-10 Finland

Dyspnoea

1.7

29.3

694

4461

3899X

ICD-9 Finland

Deafness, Unspecified deafness

+∞

29.2

H71

ICD-10 Finland

Cholesteatoma of middle ear

10.4

28.9

A98

ICPC

Health maint/preventive medicine

1.9

28.7

2495

22586

RK420

NOMESCO Finland

104.4

28.7

H92.0

ICD-10 Finland

Otalgia

3.6

28.1

131

375

DDA00

NOMESCO Finland

Stapedotomy

24.7

27.9

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

6.4

27.6

119

A28

ICPC

Limited function/disability NOS

1.9

27.6

492

2879

OAB42

SPAT

3.1

27.6

158

529

H83.3

ICD-10 Finland

Noise effects on inner ear

9.8

27.2

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.8

27.1

508

3016

R01AD09

ATC

mometasone; nasal

1.6

27.0

1031

7517

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.3

26.9

140

437

J01DB01

ATC

cefalexin; oral

1.6

26.7

2094

18104

H65.3

ICD-10 Finland

Chronic mucoid otitis media

5.9

26.6

129

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

6.1

26.3

123

H90.8

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unspecified

52.2

26.2

M54.5

ICD-10 Finland

Low back pain

1.6

26.0

775

5289

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.7

25.5

115

321

ZYC01

SPAT

2.9

25.0

161

583

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.2

24.6

275

1335

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

24.4

856

6074

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

5.7

24.1

125

DFF59

NOMESCO Finland

Other assessment of balance

12.5

24.0

R4110

SPAT

3.7

23.5

104

286

M25.5

ICD-10 Finland

Pain in joint

1.6

23.4

654

4365

H81.3

ICD-10 Finland

Other peripheral vertigo

3.8

22.8

268

H02AB06

ATC

prednisolone; systemic

1.5

22.7

1196

9282

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.6

22.6

169

670

Z01.7

ICD-10 Finland

Laboratory examination

2.0

22.3

301

1581

H60.3

ICD-10 Finland

Other infective otitis externa

4.7

22.2

169

38699

ICD-8 Finland

13.3

21.9

H90.2

ICD-10 Finland

Conductive hearing loss, unspecified

63.0

21.9

G44.2

ICD-10 Finland

Tension-type headache

2.0

21.8

304

1617

H84

ICPC

Presbyacusis

3.8

21.7

249

RK530

NOMESCO Finland

115.9

21.6

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

21.6

873

6370

RK120

NOMESCO Finland

17.6

21.3

38110

ICD-8 Finland

Otitis media without mention of mastoiditis, Chronic

10.1

21.3

L28

ICPC

Limited function/disability (L)

1.7

21.0

450

2774

D33.30

ICD-10 Finland

Acoustic neuroma

18.0

20.8

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

11.7

20.7

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

20.7

627

4254

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

20.7

525

3395

78159

ICD-8 Finland

Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD

30.3

20.5

R53

ICD-10 Finland

Malaise and fatigue

1.7

20.5

544

3561

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

20.4

1020

7770

J01CA04

ATC

amoxicillin; systemic

1.5

20.2

1993

17425

F51.0

ICD-10 Finland

Nonorganic insomnia

2.0

19.8

285

1532

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

19.7

691

4854

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.6

19.5

147

585

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.0

19.4

275

1469

AXX01

SPAT

5.2

19.2

118

R4130

NOMESCO Finland

Speech therapy

3.5

18.7

251

R05

ICD-10 Finland

Cough

1.7

18.7

467

3003

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

18.6

446

2833

R5110

SPAT

3.3

18.5

291

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

18.3

544

3658

R03AC02

ATC

salbutamol; inhalant

1.4

18.3

1240

9982

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.0

18.3

243

1268

AA1AD

NOMESCO Finland

CT of head and brain

1.6

18.1

622

4331

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

6.7

18.1

ZXH06

SPAT

3.5

18.0

243

H91

ICD-10 Finland

Other hearing loss

8.1

18.0

G04CA02

ATC

tamsulosin; oral

1.5

17.8

662

4700

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

17.7

550

3735

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

17.6

405

2539

Z00.8

ICD-10 Finland

Other general examinations

2.2

17.6

185

874

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

17.6

572

3931

H80.1

ICD-10 Finland

Otosclerosis involving oval window, obliterative

21.0

17.3

R05

ICPC

Cough

1.6

17.1

517

3483

ZX120

NOMESCO Finland

Intravenous

1.9

17.1

267

1477

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.7

16.8

113

422

H53.1

ICD-10 Finland

Subjective visual disturbances

2.3

16.8

152

669

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

3.3

16.8

268

RK290

NOMESCO Finland

16.4

16.5

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

16.5

720

5278

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.8

16.5

308

1809

WZC00

SPAT

2.7

16.3

112

423

Z29.0

ICD-10 Finland

Isolation

11.2

16.2

TDA90

NOMESCO Finland

Removal wax from ear

6.3

16.1

Z3226

NOMESCO Finland

Physiotherapist

1.6

16.0

494

3344

N06AX11

ATC

mirtazapine; oral

1.5

15.7

743

5532

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

3.4

15.6

223

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

15.6

162

762

XG460

NOMESCO Finland

Short time oxymetry

3.6

15.5

198

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

15.4

174

846

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

15.4

349

2176

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

15.2

596

4256

H65.2

ICD-10 Finland

Chronic serous otitis media

5.9

15.2

H66.9

ICD-10 Finland

Otitis media, unspecified

2.5

15.2

120

490

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

15.1

1559

13337

WZC30

NOMESCO Finland

Teaching

1.7

15.0

330

2037

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

6.1

15.0

H53.9

ICD-10 Finland

Visual disturbance, unspecified

3.1

14.9

284

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.9

14.9

224

1221

H04

ICPC

Ear discharge

2.9

14.8

305

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

14.8

166

808

N03AX16

ATC

pregabalin; oral

1.5

14.8

556

3932

S01BC05

ATC

ketorolac; ophthalmic

2.3

14.7

132

578

Z29.8

ICD-10 Finland

Other specified prophylactic measures

3.6

14.6

182

H26.4

ICD-10 Finland

After-cataract

1.8

14.6

248

1410

3897A

ICD-9 Finland

Deafness, Deaf mutism, not elsewhere classifiable[SURDITAS]

+∞

14.6

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

14.5

1152

9406

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

6.4

14.4

H02AB04

ATC

methylprednisolone; systemic

1.6

14.3

360

2307

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

14.1

1079

8738

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

14.1

486

3368

J01MA02

ATC

ciprofloxacin; systemic

1.4

14.1

981

7819

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

14.1

382

2496

J01FA10

ATC

azithromycin; systemic

1.4

14.1

1266

10537

RK220

NOMESCO Finland

10.9

14.0

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

13.8

758

5785

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

7.1

13.8

S18

ICPC

Laceration/cut

1.4

13.7

992

7946

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

13.7

256

1501

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

13.7

276

1659

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

13.6

415

2792

Z2221

NOMESCO Finland

Medical doctor

1.4

13.5

684

5135

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

13.5

423

2862

J01AA02

ATC

doxycycline; systemic

1.4

13.5

1956

17531

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

13.4

363

2370

M03BX02

ATC

tizanidine; oral

1.3

13.3

1372

11633

H01

ICPC

Ear pain/earache

1.8

13.2

218

1226

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.7

13.2

340

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

12.9

2195

20115

N30.0

ICD-10 Finland

Acute cystitis

1.6

12.9

334

2154

Z2446

NOMESCO Finland

Social worker

2.0

12.9

169

878

M79.1

ICD-10 Finland

Myalgia

1.7

12.9

262

1579

XCK00

NOMESCO Finland

Perimetry

1.9

12.8

181

966

DFX03

NOMESCO Finland

Review, maintenance and user education for hearing aid

50.2

12.8

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

12.8

865

6834

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.9

12.6

176

934

SDA02

NOMESCO Finland

Parodonthologic therapy

1.4

12.5

668

5054

Z45.3

ICD-10 Finland

Adjustment and management of implanted hearing device

+∞

12.5

A02BC03

ATC

lansoprazole; oral

1.4

12.5

719

5518

A06AD11

ATC

lactulose; oral

1.5

12.4

416

2860

N02AX02

ATC

tramadol; systemic, rectal

1.4

12.4

1035

8454

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

12.3

186

1015

XA402

NOMESCO Finland

ENMG

2.9

12.1

252

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

12.1

1131

9395

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

12.0

500

3600

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

12.0

354

2361

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.8

11.9

200

1136

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

11.9

583

4334

H65.0

ICD-10 Finland

Acute serous otitis media

4.6

11.9

ZY010

SPAT

5.3

11.8

L17

ICPC

Foot/toe symptom/complaint

1.4

11.7

558

4125

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

11.7

1355

11601

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

11.7

413

2869

H43

ICPC

Ear, Other diagnostic procedure

12.6

11.6

R06.5

ICD-10 Finland

Mouth breathing

1.9

11.6

184

1023

WX110

NOMESCO Finland

Local anesthesy

1.3

11.6

1545

13495

A02BC05

ATC

esomeprazole; systemic

1.4

11.6

921

7445

R01AD12

ATC

fluticasone furoate; nasal

1.4

11.6

557

4126

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

11.5

340

2264

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

11.5

867

6946

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

11.5

584

4371

3870A

ICD-9 Finland

Otosclerosis involving oval window, nonobliterative

10.1

11.5

38210

ICD-8 Finland

Chronic otitis media with mastoiditis

10.1

11.5

RK240

NOMESCO Finland

+∞

11.5

3898X

ICD-9 Finland

Deafness, Other specified forms of deafness

+∞

11.5

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

11.4

222

1319

K30

ICD-10 Finland

Functional dyspepsia

1.7

11.4

222

1319

R5140

SPAT

7.5

11.4

UJF32

NOMESCO Finland

Coloscopy

1.4

11.4

615

4656

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

5.0

11.4

J45.8

ICD-10 Finland

Mixed asthma

2.5

11.4

346

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.7

11.3

262

1637

XG405

NOMESCO Finland

Education on PEF monitoring

3.6

11.3

142

M01AX05

ATC

glucosamine; oral

1.5

11.2

494

3595

N17

ICPC

Vertigo/dizziness

1.7

11.2

251

1555

J01FA06

ATC

roxithromycin; oral

1.3

11.1

944

7703

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

5.0

11.1

XF404

NOMESCO Finland

Ambulatory ECG

1.7

11.1

237

1452

XKD00

NOMESCO Finland

Uroflowmetry

1.5

11.0

412

2896

Z3231

NOMESCO Finland

Registered nurse

1.4

11.0

670

5176

IHA10

SPAT

7.4

10.9

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.5

10.9

378

2611

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

10.9

151

801

M01AB05

ATC

diclofenac; systemic, rectal

1.3

10.8

1558

13692

R13

ICD-10 Finland

Dysphagia

1.9

10.8

157

848

C10AA01

ATC

simvastatin; oral

1.3

10.8

1154

9724

OAB44

SPAT

2.5

10.8

346

RL210

NOMESCO Finland

8.9

10.7

S02CA02

ATC

flumetasone and antiinfectives; otic

2.0

10.7

140

727

G47.3

ICD-10 Finland

Sleep apnoea

1.5

10.7

433

3092

3853A

ICD-9 Finland

Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid

21.5

10.7

U02

ICPC

Urinary frequency/urgency

1.6

10.7

285

1853

Z71.9

ICD-10 Finland

Counselling, unspecified

2.0

10.6

135

694

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

10.6

209

1246

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

10.6

787

6272

R03AC03

ATC

terbutaline; inhalant

1.6

10.6

308

2042

S29

ICPC

Skin symptom/complaint other

1.5

10.5

371

2574

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.8

10.5

176

998

P01

ICPC

Feeling anxious/nervous/tense

1.9

10.4

163

903

38910

ICD-8 Finland

Other deafness, Deafness, one ear and partial deafness in other

+∞

10.4

K02.1

ICD-10 Finland

Caries of dentine

1.3

10.4

1183

10040

H93.2

ICD-10 Finland

Other abnormal auditory perceptions

6.8

10.4

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

10.3

1003

8321

M54.3

ICD-10 Finland

Sciatica

2.0

10.2

136

712

H03

ICPC

Tinnitus, ringing/buzzing ear

3.4

10.1

139

H60

ICD-10 Finland

Otitis externa

2.3

10.1

414

M01AH05

ATC

etoricoxib; oral

1.3

10.1

1271

10922

H60.8

ICD-10 Finland

Other otitis externa

2.8

10.1

226

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

10.1

486

3594

R60.0

ICD-10 Finland

Localized oedema

1.6

10.1

268

1738

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.4

10.1

356

R74

ICPC

Upper respiratory infection acute

1.4

10.0

506

3772

H72.2

ICD-10 Finland

Other marginal perforations of tympanic membrane

11.3

10.0

Z00.0

ICD-10 Finland

General medical examination

1.5

9.9

414

2977

R50.9

ICD-10 Finland

Fever, unspecified

1.5

9.9

312

2110

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.5

9.9

306

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

9.8

833

6758

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

9.8

138

737

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

9.8

142

767

R06AX27

ATC

desloratadine; oral

1.4

9.8

521

3923

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

9.7

138

740

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

9.7

320

2186

R01AD08

ATC

fluticasone; nasal

1.4

9.7

582

4474

R55

ICD-10 Finland

Syncope and collapse

1.6

9.6

275

1821

R5599

NOMESCO Finland

Other rehabilitation service

2.7

9.5

232

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.9

9.5

146

806

R5430

NOMESCO Finland

Interpreter's services

10.1

9.5

H91.3

ICD-10 Finland

Deaf mutism, not elsewhere classified

100.3

9.4

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

9.4

609

4737

DE2CM

NOMESCO Finland

Acoustic channel extensive MRI examination with 3 Tesla magnet

30.1

9.4

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

9.4

792

6416

C10AA07

ATC

rosuvastatin; oral

1.4

9.4

547

4178

DC1AI

NOMESCO Finland

Cone beam CT of ear

+∞

9.4

38801

ICD-8 Finland

Deaf mutism, Congenita

+∞

9.4

J01DA01

ATC

[U] cefalexin; systemic

1.3

9.4

1508

13334

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

9.3

320

2203

C07AB07

ATC

bisoprolol; oral

1.3

9.3

1228

10579

KMAK

NOMESCO Finland

1.3

9.3

1073

9083

R07.3

ICD-10 Finland

Other chest pain

1.6

9.2

212

1326

M02AA07

ATC

piroxicam; topical

1.3

9.1

870

7170

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

9.1

375

2688

A49

ICPC

General and Unspecified, Other preventive procedure

4.6

9.1

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

9.1

321

2226

DCD00

NOMESCO Finland

Myringoplasty

6.3

9.1

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.9

9.0

179

R4120

NOMESCO Finland

Occupational therapy

1.8

9.0

149

846

N05BA04

ATC

oxazepam; oral

1.4

8.9

561

4337

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

8.9

492

3726

WX002

NOMESCO Finland

Sedation and analgesia

1.4

8.9

451

3362

R5130

SPAT

12.6

8.9

M54

ICD-10 Finland

Dorsalgia

1.6

8.8

232

1501

ZY010

NOMESCO Finland

Hospital outpatient

2.1

8.8

437

R52.9

ICD-10 Finland

Pain, unspecified

1.7

8.8

182

1103

4133

FHL

Stapedectomy sampling

8.6

8.8

S20.2

ICD-10 Finland

Contusion of thorax

1.9

8.8

118

621

H72.9

ICD-10 Finland

Perforation of tympanic membrane, unspecified

5.6

8.7

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

8.7

287

1960

H66.2

ICD-10 Finland

Chronic atticoantral suppurative otitis media

50.1

8.7

M01AC06

ATC

meloxicam; systemic, rectal

1.3

8.7

804

6588

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.6

8.6

216

1379

H69.0

ICD-10 Finland

Patulous Eustachian tube

7.6

8.6

Z01.2

ICD-10 Finland

Dental examination

1.3

8.6

825

6790

R09.8

ICD-10 Finland

Other specified symptoms and signs involving the circulatory and respiratory systems

5.2

8.6

XQ800

NOMESCO Finland

Prick test

1.8

8.5

136

762

R21

ICPC

Throat symptom/complaint

1.5

8.5

338

2403

N05CF01

ATC

zopiclone; oral

1.3

8.5

796

6531

4147

FHL

Radical surgery, cavity filling and middle ear and / or eardrum plastic

20.1

8.5

D01

ICPC

Abdominal pain/cramps general

1.6

8.4

200

1262

D07AC01

ATC

betamethasone; topical

1.3

8.4

770

6292

N05AX08

ATC

risperidone; systemic

1.6

8.4

198

1245

SPAT1229

SPAT

Assessment of need for aid

1.6

8.4

193

1204

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

8.4

103

525

R02

ICPC

Shortness of breath/dyspnoea

1.5

8.4

269

1825

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

8.4

149

865

DCD10

NOMESCO Finland

Tympanoplasty

12.8

8.4

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

8.3

595

4688

DEE00

NOMESCO Finland

Osseous fixation of hearing aid

+∞

8.3

N03AX12

ATC

gabapentin; oral

1.5

8.3

319

2252

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

8.3

1161

10028

R4160

SPAT

10.8

8.3

S06.0

ICD-10 Finland

Concussion

1.6

8.3

223

1452

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

8.3

232

1527

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

8.2

473

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

2.3

8.2

315

Z02.4

ICD-10 Finland

Examination for driving licence

1.3

8.2

548

4274

H90

ICD-10 Finland

Conductive and sensorineural hearing loss

14.5

8.2

9560/0-C72.4

ICD-O-3

Schwannoma, NOS, of acoustic nerve

14.5

8.2

38700

ICD-8 Finland

Other disease of ear and mastoid process, Cholesteatoma of ear

7.5

8.1

R01AD01

ATC

beclometasone; nasal

1.5

8.1

301

2111

R06AE07

ATC

cetirizine; oral

1.3

8.1

901

7556

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

8.1

115

620

L15

ICPC

Knee symptom/complaint

1.4

8.0

419

3134

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

8.0

256

1734

ZXC60

NOMESCO Finland

Application of heat

3.1

8.0

138

I49.5

ICD-10 Finland

Sick sinus syndrome

2.0

8.0

104

542

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

8.0

327

2336

R3110

NOMESCO Finland

Psychosocial training

4.6

8.0

N06AB04

ATC

citalopram; systemic

1.4

7.9

476

3647

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

7.9

252

1710

M48.0

ICD-10 Finland

Spinal stenosis

1.5

7.8

281

1956

M54.2

ICD-10 Finland

Cervicalgia

1.8

7.8

137

792

R03BA02

ATC

budesonide; inhalant

1.4

7.8

377

2782

H72.8

ICD-10 Finland

Other perforations of tympanic membrane

8.5

7.8

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

7.8

1492

13337

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

7.8

464

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

7.8

110

592

N06AX16

ATC

venlafaxine; oral

1.5

7.7

247

1677

ZXD05

NOMESCO Finland

Urgent procedure

1.3

7.7

720

5891

B01AC04

ATC

clopidogrel; oral

1.4

7.7

395

2943

Z26.8

ICD-10 Finland

Need for immunization against other specified single infectious diseases

4.2

7.7

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

7.7

128

727

H60.5

ICD-10 Finland

Acute otitis externa, noninfective

4.7

7.6

DDB00

NOMESCO Finland

Stapedectomy

18.4

7.6

J05AB01

ATC

aciclovir; systemic

1.4

7.5

432

3281

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.7

7.5

177

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

7.5

168

1042

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

7.5

253

1739

G04CA01

ATC

alfuzosin; oral

1.5

7.5

278

1947

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

4.0

7.4

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

7.4

332

2411

W42

ICD-10 Finland

Exposure to noise

80.3

7.4

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

7.4

745

6152

A27

ICPC

Fear of other disease NOS

1.9

7.4

522

DFF05

SPAT

7.7

7.4

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.1

7.4

356

WX402

NOMESCO Finland

General anaesthesia

1.4

7.4

327

2376

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

7.3

152

926

H51

ICPC

Ear, I&d/flush/aspiration

3.1

7.3

119

R2110

NOMESCO Finland

Giving the first information

1.7

7.3

141

838

CK2S4

SPAT

4.3

7.3

3882A

ICD-9 Finland

Other disorders of ear, Sudden hearing loss, unspecified

+∞

7.3

H95.1

ICD-10 Finland

Other disorders following mastoidectomy

+∞

7.3

R31

ICD-10 Finland

Unspecified haematuria

1.5

7.3

246

1690

N05AB04

ATC

prochlorperazine; systemic, rectal

2.3

7.3

276

XG466

NOMESCO Finland

Sleep oxymetry

2.1

7.2

387

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

7.2

388

2915

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

7.2

265

1853

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

5.8

7.2

WZB00

SPAT

2.1

7.2

392

R07.0

ICD-10 Finland

Pain in throat

1.8

7.2

113

633

38790

ICD-8 Finland

Other disease of ear and mastoid process, Degeneratio nervi acustici

20.1

7.1

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

7.1

221

1491

M02AA10

ATC

ketoprofen; topical

1.4

7.1

345

2546

R03DC03

ATC

montelukast; oral

1.4

7.1

298

2139

J02AC01

ATC

fluconazole; systemic

1.3

7.1

785

6551

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.6

7.1

175

1115

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.0

7.1

436

R31

NOMESCO Finland

Adaptation training

12.0

7.1

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

7.0

300

2163

SPAT1325

SPAT

Vaccination

1.3

7.0

796

6667

RK510

NOMESCO Finland

10.0

7.0

G04BD12

ATC

mirabegron; oral

1.5

7.0

221

1496

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

3.2

7.0

107

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

7.0

419

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.5

7.0

219

1482

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.7

7.0

133

793

XF402

NOMESCO Finland

ECG with work load test

1.5

6.9

256

1793

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

6.9

358

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

6.9

477

R06AX22

ATC

ebastine; oral

1.4

6.9

322

2360

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

6.8

216

1463

H01.0

ICD-10 Finland

Blepharitis

1.8

6.8

102

561

38401

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva

9.3

6.8

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

6.8

154

961

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.2

6.8

299

P06

ICPC

Sleep disturbance

1.6

6.8

173

1113

DCA30

NOMESCO Finland

Exploration of middle ear

40.1

6.8

UKC02

NOMESCO Finland

Cystoscopy

1.4

6.7

391

2975

-44

ICPC

Preventive immunization/medic

0.6

6.7

1304

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

6.7

191

1266

N42.9

ICD-10 Finland

Disorder of prostate, unspecified

2.7

6.7

151

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

4.1

6.7

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.9

6.7

542

SPAT1301

SPAT

No procedures

1.3

6.7

712

5913

F34.1

ICD-10 Finland

Dysthymia

2.2

6.7

304

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

6.6

195

1301

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

6.6

406

3113

G51.0

ICD-10 Finland

Bell palsy

2.3

6.6

242

R83

ICPC

Respiratory infection other

1.4

6.6

392

2992

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.1

6.6

112

L01

ICPC

Neck symptom/complaint

1.5

6.6

253

1784

TQW40

SPAT

2.1

6.6

331

S06

ICPC

Rash localized

1.8

6.6

106

597

A04

ICPC

Weakness/tiredness general

1.4

6.6

287

2078

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

4.0

6.6

R4190

NOMESCO Finland

Nutritional therapy

2.0

6.6

368

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

3.9

6.6

J34.2

ICD-10 Finland

Deviated nasal septum

1.8

6.6

100

553

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

6.5

301

2199

R30.0

ICD-10 Finland

Dysuria

2.1

6.5

347

J01EA01

ATC

trimethoprim; systemic

1.3

6.5

573

4642

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

6.5

219

1508

S00.0

ICD-10 Finland

Superficial injury of scalp

2.4

6.4

210

M54.1

ICD-10 Finland

Radiculopathy

2.0

6.4

404

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

6.4

380

2902

Z50.5

ICD-10 Finland

Speech therapy

3.1

6.4

109

D06

ICPC

Abdominal pain localized other

1.6

6.4

141

876

WX702

NOMESCO Finland

Supraglottic ventilation device

1.8

6.4

101

568

L57.0

ICD-10 Finland

Actinic keratosis

1.5

6.4

224

1554

Z97.8

ICD-10 Finland

Presence of other specified devices

14.3

6.4

C10AA05

ATC

atorvastatin; oral

1.2

6.4

904

7752

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

6.4

336

2517

N03AE01

ATC

clonazepam; systemic

1.7

6.4

122

728

R51

ICD-10 Finland

Headache

1.9

6.4

480

U07

ICPC

Urine symptom/complaint other

1.7

6.3

122

729

R05FB02

ATC

cough suppressants and expectorants

1.2

6.3

882

7549

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

6.3

118

696

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

6.3

118

697

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

6.3

140

870

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

6.3

422

3284

J01DC02

ATC

cefuroxime; systemic

1.7

6.3

113

662

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

6.3

583

4750

P01AB01

ATC

metronidazole; oral, rectal

1.2

6.3

823

6995

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

6.3

143

894

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

6.3

591

4822

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

3.5

6.3

K85

ICPC

Elevated blood pressure

1.4

6.3

320

2380

N06AX21

ATC

duloxetine; oral

1.5

6.3

195

1316

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

9.3

6.3

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

2.7

6.3

146

3890A

ICD-9 Finland

Deafness, Conductive deafness

+∞

6.2

DE2DG

NOMESCO Finland

Acoustic channel very extensive MRI examination with high intensity magnet

+∞

6.2

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

2.2

6.2

280

78139

ICD-8 Finland

Other symptoms referable to nervous system and special senses, Symptoma auditus aliud sive NUD

26.7

6.2

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

6.2

134

825

H70.1

ICD-10 Finland

Chronic mastoiditis

7.0

6.2

C05AA08

ATC

fluocortolone; rectal, topical

1.4

6.2

290

2127

XJH00

NOMESCO Finland

Transanal ultrasonography

1.6

6.2

164

1066

R35

ICD-10 Finland

Polyuria

1.6

6.2

145

918

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

2.5

6.1

184

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

6.1

423

3302

M01AX17

ATC

nimesulide; oral

1.3

6.1

546

4424

A11

ICPC

Chest pain NOS

1.6

6.1

157

1012

K03.80

ICD-10 Finland

Irradiated enamel

2.0

6.1

364

H74.2

ICD-10 Finland

Discontinuity and dislocation of ear ossicles

12.5

6.1

DGW00

NOMESCO Finland

Dilatation of eustachian tube

12.5

6.1

50499

ICD-8 Finland

Deflected nasal septum

2.4

6.1

197

G30.1

ICD-10 Finland

Alzheimer disease with late onset

1.6

6.1

158

1023

D11

ICPC

Diarrhoea

1.5

6.1

197

1344

H71

ICPC

Acute otitis media/myringitis

3.7

6.1

RS130

NOMESCO Finland

10.0

6.0

C01DA14

ATC

isosorbide mononitrate; oral

1.3

6.0

432

3393

-1

NOMESCO Finland

1.3

6.0

631

5217

J30.3

ICD-10 Finland

Other allergic rhinitis

2.1

6.0

305

J45

ICD-10 Finland

Asthma

1.5

6.0

180

1204

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

859

4376

2.31

87.41

3.5

3.0

e6/l

3.1

2.3

1.42

542

2395

(40758558) Short blood count panel - Blood

1144

6561

2.14

86.62

7.1

6.5

—

(3000034) Microalbumin [Mass/volume] in Urine

138

217

6.60

84.16

3.3

3.0

mg/l

63.8

34.3

0.77

104

161

(4034850)

264

752

3.73

79.32

8.6

10.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

744

3844

2.21

71.31

19.5

26.7

inr

1.3

1.4

0.52

534

(3022689) Creatine [Moles/volume] in Urine

12.13

68.69

1.3

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

9.19

65.59

2.9

2.3

—

(3002385) Erythrocyte distribution width [Ratio]

2514

20334

2.03

61.55

24.8

18.9

13.9

13.8

0.95

2486

19830

(3018095) Leukocytes [#/volume] in Urine

1381

9415

1.81

56.72

5.5

3.8

e6/l

128.6

122.6

0.05

1034

6778

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1631

11901

1.74

51.22

7.4

6.1

mmol/l

1.2

1.24

1543

10738

(3002582) Erythrocytes [#/volume] in Urine

1224

8238

1.78

51.05

4.1

3.3

e6/l

58.2

86.4

0.69

955

6368

(3019550) Sodium [Moles/volume] in Serum or Plasma

2925

25766

2.30

46.85

22.4

18.0

mmol/l

139.6

0.04

2895

25050

(3023103) Potassium [Moles/volume] in Serum or Plasma

2929

25832

2.30

46.50

22.6

18.2

mmol/l

4.0

0.52

2894

25067

(3044889) 12 lead EKG panel

2191

17636

1.74

45.82

4.1

3.9

—

(3021589) Normoblasts [#/volume] in Blood

1506

11111

1.66

42.51

10.7

9.7

e9/l

0.0

1.55

1247

8984

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2825

24779

2.04

42.11

19.8

15.5

mg/l

24.5

25.8

1.28

2376

19976

(3011397) Hemoglobin [Presence] in Urine by Test strip

908

5873

1.76

41.70

3.7

—

(3019150) Specific gravity of Urine by Refractometry

832

5280

1.77

40.66

4.1

4.2

kg/l

1.0

0.11

842

(3031040) Bacteria [#/volume] in Urine by Automated count

2090

16901

1.66

39.94

5.5

4.7

e6/l

1168.7

2254.4

0.38

273

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2923

26132

2.13

38.69

11.5

10.6

u/l

25.2

25.6

0.58

2859

25099

(3033658) Prothrombin time (PT) actual/Normal

998

6760

1.69

38.11

3.8

4.1

88.2

87.0

0.82

974

6587

(3021601) Nitrite [Presence] in Urine by Test strip

1595

12154

1.61

37.99

5.3

5.0

estimate

0.0

0.50

252

2260

(3014111) Lactate [Moles/volume] in Serum or Plasma

459

2463

2.00

37.62

6.7

6.8

mmol/l

1.4

0.02

405

2361

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1444

10823

1.60

36.28

2.2

2.0

pmol/l

95.2

93.1

1.04

813

5570

(40761511) CBC panel - Blood by Automated count

2857

25469

1.98

36.01

18.6

14.4

—

(3009261) Glucose [Presence] in Urine by Test strip

1600

12302

1.59

35.96

4.1

3.7

estimate

0.0

0.50

255

2203

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2332

19641

1.66

35.57

7.8

7.5

u/l

79.2

80.4

0.56

2222

18436

(3024731) MCV [Entitic volume]

2998

27268

2.22

34.66

27.6

22.4

91.4

91.3

0.27

2975

26771

(3035941) MCH [Entitic mass]

2998

27269

2.22

34.64

27.6

22.4

30.4

0.92

2976

26771

(3026361) Erythrocytes [#/volume] in Blood

2998

27271

2.22

34.60

27.7

22.5

e12/l

4.4

2.71

2922

26339

(3035350) Ketones [Presence] in Urine by Test strip

1574

12126

1.58

34.57

4.0

3.7

estimate

0.0

0.00

200

2230

(3007461) Platelets [#/volume] in Blood

2997

27261

2.21

34.55

27.7

22.5

e9/l

242.2

247.7

4.71

2930

26433

(3000963) Hemoglobin [Mass/volume] in Blood

2998

27279

2.21

34.44

27.8

22.6

g/l

133.1

133.8

1.86

2973

26789

(3010813) Leukocytes [#/volume] in Blood

2998

27279

2.21

34.44

27.7

22.5

e9/l

6.8

6.9

0.01

2921

26340

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1674

13165

1.56

32.96

7.4

6.8

mmol/l

1.2

0.01

1526

11069

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

118

352

3.44

32.85

1.6

1.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1364

10260

1.57

32.64

2.3

2.2

nmol/l

78.3

78.1

0.12

1274

9085

(3030467) Casts [#/volume] in Urine by Automated count

1053

7515

1.59

31.32

3.6

3.2

e6/l

0.5

0.11

773

5708

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

321

1615

2.10

31.12

1.8

1.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1866

15148

1.54

31.00

5.6

4.7

mmol/l

6.8

0.13

1774

14190

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2627

23131

1.70

30.46

19.1

14.8

ml/min/173m2

76.6

77.4

1.20

2228

19092

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2561

22409

1.66

30.32

5.2

4.7

mu/l

1.9

2.1

1.17

2410

20275

(3026782) Osmolality of Urine

796

5390

1.63

29.05

4.0

2.7

mosm/kgh2o

547.2

551.1

0.21

694

4574

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1088

7986

1.54

27.87

3.4

3.1

ng/l

1669.1

1787.8

0.39

975

6922

(3018418) pH of Serum or Plasma

1076

7894

1.54

27.55

4.5

4.0

7.4

0.06

121

1472

(3013707) Erythrocyte sedimentation rate by Westergren method

2166

18387

1.53

27.53

4.5

4.0

mm/h

13.2

13.5

0.34

2067

16875

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1663

13412

1.49

26.76

5.9

6.2

umol/l

12.5

12.1

0.23

1593

12721

(3003338) MCHC [Mass/volume]

2374

20639

1.55

26.32

24.0

20.1

g/l

331.4

331.8

0.89

2358

20414

(3037467) Urinalysis macro (dipstick) panel - Urine

2048

17356

1.48

24.80

4.8

4.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

686

4633

1.61

24.77

3.0

2.9

e6/l

0.9

1.1

0.96

369

2642

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2658

23827

1.62

24.71

4.8

4.7

mmol/l

6.0

0.11

2523

21458

(3029937) Albumin [Presence] in Urine by Test strip

904

6511

1.54

24.62

4.6

4.1

estimate

0.0

1.34

247

2157

(3013650) Neutrophils [#/volume] in Blood by Automated count

1772

14613

1.47

24.57

9.7

8.8

e9/l

4.2

0.15

1528

12605

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2710

24426

1.64

24.45

5.3

5.0

mmol/l

2.6

2.7

1.11

2581

22250

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

765

5316

1.57

24.43

3.8

ng/l

548.4

590.1

0.06

594

4362

(3024561) Albumin [Mass/volume] in Serum or Plasma

1436

11394

1.46

24.20

5.0

4.8

g/l

35.1

34.9

0.70

1355

10524

(3045424) Erythrocytes [Presence] in Urine

114

401

2.91

24.13

1.9

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

871

6289

1.53

23.21

1.7

1.6

nmol/l

21.6

20.2

1.71

800

5383

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1261

9841

1.46

22.73

4.7

3.8

ng/l

40.2

97.3

0.70

905

7109

(3026008) Bacteria identified in Urine by Culture

1080

8212

1.47

22.12

3.6

3.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2138

18473

1.46

21.92

4.2

3.9

pmol/l

15.0

14.9

0.65

1999

16652

(3007853) Bacteria identified in Skin by Aerobe culture

457

2895

1.67

21.00

2.1

1.8

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

613

4177

1.58

20.92

2.2

2.1

30.1

29.9

0.29

607

4040

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2527

22657

1.51

20.72

6.2

6.0

mmol/mol

40.3

40.4

0.04

2422

20798

(3014576) Chloride [Moles/volume] in Serum or Plasma

520

3415

1.62

20.71

8.2

6.8

mmol/l

104.3

104.4

0.16

511

3331

(3006315) Basophils [#/volume] in Blood

1526

12490

1.42

20.50

6.4

5.6

e9/l

0.0

1.03

1307

10623

(3001604) Monocytes [#/volume] in Blood

1519

12433

1.41

20.35

6.4

5.6

e9/l

0.6

0.60

1306

10564

(3042936) Bacteria identified in Isolate by Culture

544

3648

1.59

19.79

2.2

2.0

—

(3013115) Eosinophils [#/volume] in Blood

1561

12886

1.41

19.66

7.0

5.9

e9/l

0.2

0.27

1356

11114

(3019198) Lymphocytes [#/volume] in Blood

1549

12779

1.40

19.53

6.5

5.7

e9/l

1.9

0.30

1344

11059

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1293

10370

1.41

19.06

3.1

2.8

ug/l

152.2

137.9

0.62

1216

9522

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2623

23840

1.51

18.80

4.5

4.4

mmol/l

4.5

4.6

3.80

2505

21856

(42870588) Differential panel, method unspecified - Blood

1099

8587

1.42

18.71

6.4

5.7

—

(36304419) Bacteria [Presence] in Urine

960

7320

1.44

18.69

3.6

3.2

—

(3045414) Leukocytes [Presence] in Urine

218

1149

1.96

18.42

2.2

1.9

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

407

2586

1.66

18.36

7.8

7.7

g/l

120.6

120.4

0.05

397

2485

(3044640) Blood type and Crossmatch panel - Blood

1051

8176

1.42

18.23

2.6

2.5

—

(3016502) Oxygen saturation in Arterial blood

434

2834

1.61

17.50

7.5

7.3

95.4

0.00

423

2723

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

698

5077

1.48

17.17

3.0

mmol/l

2.5

0.21

612

4413

(3003396) Base excess in Arterial blood by calculation

471

3192

1.56

16.13

7.1

6.9

mmol/l

0.8

1.1

0.94

393

2469

(3027801) Oxygen [Partial pressure] in Arterial blood

472

3206

1.55

15.99

7.0

6.9

kpa

12.1

0.01

454

3030

(3026493) Urate [Moles/volume] in Serum or Plasma

868

6651

1.42

15.98

2.7

umol/l

5546.0

6207.2

0.15

767

5695

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

472

3207

1.55

15.97

7.0

6.9

kpa

5.1

0.37

455

3029

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

998

7857

1.39

15.61

2.7

2.5

u/l

59.5

58.8

0.09

955

7232

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2579

23622

1.44

15.36

4.3

4.4

mmol/l

1.4

1.5

2.68

2447

21506

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

307

1922

1.66

14.56

1.6

—

(3020891) Body temperature

192

1051

1.88

14.49

7.5

4.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

458

3157

1.52

14.42

2.0

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

168

3005

0.54

14.07

5.0

4.5

31.6

32.9

0.90

125

1943

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1131

9200

1.35

14.06

4.4

4.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

996

7946

1.36

14.04

3.4

3.2

u/l

29.8

37.8

2.63

942

7510

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

455

3150

1.52

14.01

2.0

1.8

—

(3019069) Monocytes/100 leukocytes in Blood

1407

11838

1.33

13.87

6.8

6.1

9.0

8.8

1.38

1340

10997

(3006504) Eosinophils/100 leukocytes in Blood

1401

11784

1.33

13.82

6.6

5.8

2.7

2.8

1.36

1327

10905

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

429

2943

1.53

13.78

3.0

2.7

umol/l

8.7

9.2

0.15

379

2551

(3022096) Basophils/100 leukocytes in Blood

1366

11452

1.33

13.77

6.7

5.9

0.6

0.7

0.31

1296

10614

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

371

2472

1.57

13.59

2.6

2.4

u/l

33.5

38.1

0.85

315

2107

(3018010) Neutrophils/100 leukocytes in Blood

1414

11933

1.33

13.54

6.5

5.8

58.2

57.8

0.54

1344

11090

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

867

6813

1.37

13.31

2.3

2.2

mg/l

2.9

3.0

0.53

757

5785

(3015377) Calcium [Moles/volume] in Serum or Plasma

1089

8864

1.34

13.31

3.4

mmol/l

2.3

2.4

0.53

979

7680

(3000494) Fungus identified in Specimen by Culture

408

2796

1.52

13.14

1.5

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

822

6416

1.38

13.13

1.7

1.6

mmol/l

1.4

0.07

738

5387

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1594

13732

1.31

12.97

2.9

2.7

—

(3002030) Lymphocytes/100 leukocytes in Blood

1428

12120

1.32

12.92

6.7

6.0

26.7

27.1

0.70

1358

11201

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2483

22813

1.37

12.73

3.9

4.0

mmol/l

1.3

1.00

2329

20594

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

471

3348

1.48

12.68

1.5

1.4

—

(3019225) pH of Specimen

141

2570

0.53

12.52

3.8

4.5

—

(3015736) pH of Urine

1141

9429

1.32

12.33

3.7

3.5

—

5.8

—

(3023368) Bacteria identified in Blood by Culture

948

7631

1.34

12.27

5.2

4.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

499

3616

1.45

12.12

2.8

2.6

22.4

22.2

0.12

428

3087

(3022948) Iron [Moles/volume] in Serum or Plasma

561

4168

1.42

11.87

2.7

2.5

umol/l

12.8

12.6

0.28

529

3842

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

968

7891

1.32

11.30

2.3

2.1

u/l

188.2

214.2

0.43

929

7367

(3004789) Transferrin [Mass/volume] in Serum or Plasma

520

3850

1.42

11.17

2.8

2.5

g/l

2.3

0.49

487

3550

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

242

1528

1.63

11.08

8.6

8.9

mmol/l

24.4

0.01

215

1418

(3007164) IgA [Mass/volume] in Serum or Plasma

579

4414

1.38

10.42

1.5

1.4

g/l

2.3

2.5

1.49

344

2601

(3000991) Gas panel - Venous blood

340

2371

1.48

9.99

9.4

7.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

509

3834

1.39

9.81

1.3

iu/ml

27.4

36.6

1.15

142

1235

(3024354) Oxygen [Partial pressure] in Venous blood

317

2190

1.50

9.76

3.9

3.3

kpa

4.5

4.6

0.06

299

2106

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

203

3143

0.62

9.69

6.9

7.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

147

845

1.77

9.55

2.3

2.2

g/l

0.0

0.21

137

768

(3000850) Epithelial cells [#/volume] in Urine

718

5758

1.32

9.11

2.9

2.6

e6/l

4.0

5.5

4.27

572

5051

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

261

2.36

8.92

1.3

mmol/l

8.6

7.5

1.25

188

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

230

1514

1.56

8.86

2.5

2.4

au/ml

33.1

21.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

251

1692

1.52

8.69

7.5

6.6

mmol/l

24.6

0.02

237

1562

(40768797) Stomach Pathology biopsy report

449

3382

1.38

8.60

1.3

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

367

2672

1.42

8.57

4.5

3.9

kpa

5.8

0.11

348

2577

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1048

8884

1.26

8.53

5.1

ug/l

3.5

0.01

968

7883

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

174

1104

1.61

7.87

2.7

2.2

g/l

3.8

0.19

111

811

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

155

956

1.65

7.85

2.3

g/l

0.7

1.0

0.51

139

819

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

174

1105

1.61

7.84

2.7

2.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

660

5329

1.30

7.83

2.0

1.8

mg/l

1.5

1.4

0.38

505

4110

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

174

1106

1.61

7.81

2.7

2.2

g/l

7.2

7.5

0.89

114

843

(3022145) Colonoscopy Study observation

353

2605

1.40

7.62

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

536

1.83

7.26

1.2

1.5

e6/l

40.4

29.7

0.12

414

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

162

1035

1.59

7.15

2.6

2.3

g/l

3.0

3.1

1.03

111

826

(3015235) Bicarbonate [Moles/volume] in Capillary blood

119

702

1.72

7.14

3.7

3.5

mmol/l

24.4

25.1

0.84

104

612

(3012095) Magnesium [Moles/volume] in Serum or Plasma

546

4349

1.31

7.12

3.7

3.2

mmol/l

0.8

0.20

506

4038

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

537

1.81

6.92

1.3

1.6

e6/l

477.4

1471.0

1.02

436

(3049717) Cytology report of Urine Cyto stain

169

1100

1.57

6.90

2.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

408

3131

1.35

6.89

4.3

4.1

u/l

235.8

248.4

1.15

391

2942

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1010

0.46

6.88

1.9

1.8

—

(3002256) Pathology report gross observation

432

3350

1.33

6.80

1.4

1.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

191

1282

1.52

6.79

4.5

2.7

1.3

1.2

0.62

191

1271

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

206

1405

1.50

6.78

3.7

4.1

mmol/l

23.9

24.1

0.22

180

1264

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

608

4943

1.28

6.75

1.3

1.2

u/ml

0.9

1.7

2.21

191

1254

(3002032) Base excess in Venous blood by calculation

354

2668

1.37

6.72

4.6

3.9

mmol/l

1.9

2.0

0.15

297

2126

(3027945) Reticulocytes/100 erythrocytes in Blood

417

3223

1.34

6.71

2.6

2.5

1.7

1.8

0.51

389

2825

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

103

598

1.75

6.57

2.0

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

244

1733

1.44

6.54

1.9

1.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

275

2000

1.41

6.47

3.5

2.7

ml/min/173m2

57.8

63.3

1.58

146

813

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1105

0.50

6.45

2.0

1.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

225

1579

1.46

6.43

1.3

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

352

2676

1.35

6.32

2.0

2.1

ug/g

144.6

139.3

0.09

278

2086

(3023520) Reticulocytes [#/volume] in Blood

320

2404

1.37

6.20

2.3

2.5

e9/l

64.3

68.9

1.95

245

1774

(3020779) Urea [Moles/volume] in Serum or Plasma

328

2474

1.36

6.20

8.4

7.0

mmol/l

10.6

0.02

311

2346

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.92

6.15

1.5

1.9

ug/l

23.6

354.6

0.68

(3019060) Gas panel - Arterial blood

249

1797

1.42

6.13

4.8

4.6

—

(40768804) Tissue Pathology biopsy report

1138

10004

1.21

6.12

2.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

309

2315

1.37

6.09

2.8

2.4

g/l

65.8

66.3

0.58

290

2088

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

183

1247

1.50

6.08

4.3

2.7

0.7

0.6

0.36

175

1193

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

461

3665

1.30

6.05

1.2

u/ml

13.5

14.1

0.06

163

1381

(3043409) Potassium [Moles/volume] in Arterial blood

127

800

1.61

5.99

5.5

4.0

mmol/l

3.9

0.28

121

740

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1323

11835

1.20

5.83

4.4

4.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

448

3575

1.29

5.71

6.8

5.7

mmol/l

1.0

0.09

416

3303

(3036489) Thrombin time

144

956

1.53

5.45

1.7

2.1

22.3

21.5

0.57

133

850

(3000060) B lymphocytes [#/volume] in Blood

3.48

5.17

3.4

2.5

e6/l

6479.2

205.5

0.49

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

13.36

5.08

1.0

1.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

358

1.83

5.03

1.5

g/l

0.7

0.8

0.90

277

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

117

756

1.57

5.02

1.9

1.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

151

1034

1.48

4.96

3.5

2.9

u/ml

0.3

0.44

579

(3017446) Testosterone [Moles/volume] in Serum or Plasma

221

1628

1.38

4.87

2.2

2.1

nmol/l

11.8

12.0

0.13

189

1412

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

127

843

1.53

4.84

1.3

—

(3014891) Appearance of Pleural fluid

3.58

4.76

2.1

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

128

859

1.51

4.65

2.2

2.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

110

714

1.56

4.65

1.7

—

(4027681)

127

2.37

4.64

1.1

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

537

4486

1.24

4.62

2.0

1.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

105

677

1.57

4.58

3.1

4.3

kpa

8.1

8.0

0.26

633

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

725

6252

1.21

4.55

2.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

181

1307

1.41

4.51

1.4

1.2

u/ml

174.0

214.4

0.49

171

1198

(40761535) Cells panel - Urine sediment

274

2113

1.32

4.50

3.4

3.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

266

2053

1.32

4.35

4.5

3.9

ng/l

113.0

94.0

1.35

238

1764

(3009508) Creatinine [Moles/volume] in Urine

915

8085

1.18

4.35

3.4

3.2

mmol/l

7.2

7.3

0.21

799

6732

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

197

2.04

4.33

1.2

1.3

u/l

16.9

13.3

0.43

184

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.91

4.28

1.1

1.3

—

(40761536) Microorganisms panel - Urine sediment

149

2075

0.70

4.22

5.3

4.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.51

4.21

2.2

2.5

umol/l

25.6

29.6

0.98

(3026389) Candida sp identified in Specimen by Organism specific culture

285

1.84

4.15

1.9

1.3

—

(3025159) Blasts/100 leukocytes in Blood

252

1946

1.32

4.12

5.0

3.9

1.6

0.3

0.39

485

(3041096) Erythrocytes [Presence] in Urine by Automated

735

6415

1.19

3.99

3.8

3.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

116

790

1.49

3.98

2.0

2.2

g/l

0.0

0.00

108

725

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

117

802

1.48

3.89

2.0

2.2

g/l

0.0

0.00

108

727

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

162

2189

0.73

3.84

5.5

3.6

mmol/l

1.2

0.05

142

1897

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

628

1.53

3.77

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

628

1.53

3.77

1.4

1.3

—

(3021901) Oxygen saturation in Capillary blood

519

1.57

3.70

2.1

2.9

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

101

681

1.50

3.66

1.5

g/l

1.2

0.61

644

(3043410) Blood group antigens tested for on Red Blood Cells

2.70

3.65

2.2

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

658

1.50

3.63

1.5

g/l

0.2

0.17

623

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

328

1.72

3.62

1.9

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

599

5180

1.19

3.59

3.2

3.1

ug/l

0.9

0.8

0.17

476

3608

(3005719) IgG [Mass/volume] in Serum or Plasma

231

1800

1.30

3.57

3.3

2.7

g/l

10.4

10.6

0.22

215

1640

(3044290) Cell count panel - Cerebral spinal fluid

484

1.58

3.57

1.2

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

157

2.05

3.55

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

404

3370

1.23

3.52

1.8

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

638

5563

1.18

3.47

1.8

1.7

pmol/l

97561414.9

20915037.4

1.26

533

4614

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

124

881

1.42

3.46

2.0

2.1

g/l

37.9

37.3

0.53

108

755

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

110

765

1.45

3.44

2.5

2.4

91.6

90.1

0.31

105

724

(3014051) Protein [Presence] in Urine by Test strip

643

1.49

3.41

2.6

2.2

—

(3003694) ABO and Rh group [Type] in Blood

742

6567

1.17

3.35

1.3

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

802

7147

1.16

3.31

4.2

4.4

23.0

22.2

0.61

392

3659

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

122

2.14

3.25

1.0

1.1

u/l

1.0

1.2

0.78

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

152

1131

1.36

3.25

1.1

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

117

837

1.41

3.17

3.4

—

(3017181) Myelocytes/100 leukocytes in Blood

270

2181

1.26

3.17

4.9

3.8

0.8

0.01

630

(3021440) Promyelocytes/100 leukocytes in Blood

258

2075

1.26

3.14

5.0

3.9

0.1

0.27

586

(3023410) Appearance of Cerebral spinal fluid

245

1.77

3.11

1.4

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

231

1.78

3.08

1.2

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

140

1039

1.36

3.06

2.5

2.2

g/l

10.1

10.3

0.24

123

884

(3036481) Cortisol [Moles/volume] in Serum or Plasma

268

2174

1.25

3.04

2.1

2.2

nmol/l

374.5

373.9

0.01

245

1978

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.90

3.02

1.2

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

239

1916

1.27

3.00

2.6

2.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

2306

22138

1.14

2.99

21.2

16.9

39.6

39.1

2.82

1817

15200

(3023183) Ammonium ion [Moles/volume] in Plasma

557

1.48

2.94

2.3

2.8

umol/l

30.0

36.8

1.48

468

(3013247) Albumin in CSF/Albumin in Serum or Plasma

2.93

2.85

1.1

1.0

mg/g

5.6

10.1

1.92

(3027135) IgG subclass 1 [Mass/volume] in Serum

215

1.78

2.84

1.6

1.3

g/l

6.1

6.9

1.22

152

(3028192) IgG subclass 2 [Mass/volume] in Serum

215

1.78

2.84

1.6

1.3

g/l

2.8

3.1

0.70

150

(3024139) IgG subclass 3 [Mass/volume] in Serum

215

1.78

2.84

1.6

1.3

g/l

0.4

0.16

152

(3028026) IgM [Mass/volume] in Serum or Plasma

180

1405

1.30

2.81

1.7

1.8

g/l

1.1

1.4

1.39

165

1272

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

101

721

1.41

2.81

1.1

1.2

—

(4062490)

216

1.77

2.80

1.6

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

900

8180

1.14

2.75

4.1

4.0

mg/mmol

8.9

12.0

0.59

624

5167

(1002224) Polysomnography panel

112

818

1.38

2.74

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

177

1386

1.29

2.71

2.3

2.4

—

(4198724)

2.43

2.70

2.2

1.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

234

1.72

2.68

1.6

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.80

2.64

1.1

1.0

—

(3037522) Nuclear Ab [Titer] in Serum

358

3042

1.20

2.62

1.4

1.3

titre

714.2

512.5

0.75

647

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

113

2.04

2.61

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

100

723

1.40

2.61

1.1

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

155

1.88

2.61

1.6

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

155

1.88

2.61

1.6

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

165

1288

1.30

2.60

1.7

g/l

1.5

0.65

150

1103

(3027273) Bicarbonate [Moles/volume] in Venous blood

172

1351

1.29

2.58

5.2

3.5

mmol/l

25.3

0.00

163

1305

(3036782) Glucose [Moles/volume] in Pleural fluid

283

1.63

2.57

1.2

1.4

mmol/l

6.3

6.6

0.57

264

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

299

1.61

2.56

1.2

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

149

1.89

2.56

1.4

1.3

u/ml

0.2

1.5

0.98

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

292

1.62

2.54

3.7

3.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

108

2.04

2.51

1.1

1.3

—

69.9

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

122

1.97

2.50

1.2

1.6

66.2

69.1

0.15

103

(3015171) Extractable nuclear Ab [Units/volume] in Serum

113

841

1.36

2.49

1.3

1.2

u/ml

0.2

1.1

1.51

(42529406) Shigella sp [Presence] in Stool by Culture

100

730

1.38

2.48

1.1

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

240

1.67

2.47

1.2

1.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

205

1657

1.25

2.45

4.8

3.3

g/l

125.8

128.0

0.66

205

1610

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

533

1.44

2.38

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

345

1.55

2.37

4.4

4.9

umol/l

345.9

356.6

0.17

293

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

6.26

2.37

1.0

nmol/l

292.9

240.0

—

(3026480) Teichoate Ab [Titer] in Serum

3.64

2.36

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.64

2.36

1.0

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

162

1.80

2.31

3.2

2.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

655

1.38

2.30

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

215

1.68

2.28

1.1

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

215

1.68

2.28

1.3

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

325

1.55

2.27

1.2

1.3

nmol/l

—

0.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

134

1.87

2.26

3.0

2.5

42.5

39.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1621

15374

1.11

2.26

3.0

3.1

u/l

51.9

52.2

0.05

1517

14133

(36660697) Celiac disease serology panel - Serum

215

1767

1.23

2.24

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

191

1551

1.25

2.22

1.5

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

157

1.79

2.21

3.0

2.3

13.4

12.1

0.25

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

450

1.45

2.20

1.3

1.2

u/ml

35.6

46.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

409

1.48

2.19

1.3

1.5

g/l

34.0

31.5

0.71

364

(3003181) Sodium [Moles/volume] in Urine

476

1.44

2.17

2.3

1.4

mmol/l

65.2

60.6

0.36

368

(3017143) Hepatitis C virus Ab [Presence] in Serum

283

2400

1.20

2.15

1.7

1.5

—

(3042733) HLA Ab [Presence] in Serum

2.30

2.14

7.4

4.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

597

0.63

2.13

3.9

3.5

mg/l

26.2

28.5

0.16

385

(3019309) Folate [Moles/volume] in Red Blood Cells

575

5157

1.14

2.13

1.7

1.8

nmol/l

1259.5

1167.7

1.40

457

3850

(3038515) Glucose [Moles/volume] in Venous blood

596

0.63

2.12

4.2

3.4

mmol/l

8.0

7.7

0.18

580

(3004616) Nuclear Ab [Presence] in Serum

279

0.46

2.12

1.5

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

175

1.72

2.09

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

276

1.57

2.08

1.1

1.3

nmol/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

132

1671

0.78

2.08

1.6

1.8

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

183

1.70

2.07

1.0

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

183

1.70

2.07

1.0

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

183

1.70

2.07

1.0

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

146

1.79

2.06

3.3

1.9

e6/l

586.2

651.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

583

1.38

2.06

1.8

1.6

mu/l

361.5

301.2

0.78

531

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

184

1.69

2.04

1.0

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

184

1.69

2.04

1.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

184

1.69

2.04

1.0

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

142

1128

1.27

2.02

2.2

1.9

ug/l

1.9

2.6

0.32

131

976

(3024263) Appearance of Synovial fluid

155

1.75

2.00

2.4

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

117

909

1.30

1.98

4.4

3.1

mg/l

43.7

59.5

0.34

100

744

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

114

884

1.30

1.96

4.3

3.1

ratio

2.8

1.8

0.39

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

112

1.88

1.96

2.3

2.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

170

1385

1.24

1.95

2.8

3.3

pmol/l

4.5

4.4

0.19

153

1211

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.03

1.95

1.7

2.7

umol/l

168.7

94.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

226

1.60

1.93

1.1

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.12

1.92

1.4

1.5

iu/ml

—

1679021.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

113

1.86

1.91

1.3

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.92

1.90

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

228

1.59

1.87

2.6

2.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

291

0.51

1.86

1.3

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

600

0.66

1.85

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

287

2474

1.18

1.84

1.8

1.5

0.29

260

2128

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

290

0.52

1.84

1.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

290

0.52

1.84

1.3

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

116

911

1.28

1.83

4.5

3.1

mg/l

109.8

123.3

0.07

745

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

401

1.43

1.82

1.7

1.4

u/ml

95.7

122.4

1.29

(3023511) Choriogonadotropin [Units/volume] in Urine

246

1.55

1.81

1.4

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1035

0.75

1.79

4.4

4.6

mmol/l

25.5

24.8

0.87

942

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

299

0.53

1.77

1.3

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.09

1.76

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

741

1.30

1.74

1.4

ug/g

257.1

270.8

0.25

444

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1108

0.76

1.73

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

296

0.54

1.72

1.3

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

296

0.54

1.72

1.3

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

163

1.66

1.71

2.9

1.8

—

(3023420) DNA double strand Ab [Units/volume] in Serum

259

1.51

1.68

1.4

1.3

—

27.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

614

1.33

1.68

1.7

2.1

g/l

130.5

128.1

0.36

436

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

176

1467

1.21

1.66

9.9

9.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

284

1.49

1.66

1.1

u/ml

0.4

1.6

1.28

127

(44816559) Phosphatidylethanol [Mass/volume] in Blood

392

1.41

1.66

1.2

1.3

—

(40768443) Skin Pathology biopsy report

131

1059

1.25

1.66

1.2

—

(3011288) Drugs identified in Urine by Screen method

359

1.43

1.65

2.4

2.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

660

1.31

1.64

1.4

1.3

—

(3012441) Differential panel - Pleural fluid

319

1.45

1.62

1.5

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.58

1.61

1.0

4.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.58

1.61

2.0

8.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

671

1.30

1.61

2.5

2.4

ug/min

135.0

94.5

0.31

411

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

199

1685

1.19

1.60

2.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

489

1.36

1.60

1.4

u/l

10.1

10.3

0.03

397

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.07

1.59

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

136

1.70

1.58

5.7

6.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

248

1.50

1.55

1.2

1.1

—

4.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.34

1.52

1.4

1.1

—

(3014271) Vancomycin [Susceptibility]

140

0.43

1.52

3.2

3.1

—

(4306422)

332

1.42

1.52

1.1

1.2

—

(3013512) EKG study

793

7385

1.10

1.50

4.8

4.0

—

(3035285) Chloride [Moles/volume] in Venous blood

369

0.62

1.49

3.3

2.4

mmol/l

106.2

105.4

0.36

363

(3041354) Potassium [Moles/volume] in Venous blood

369

0.62

1.49

3.3

2.4

mmol/l

4.2

4.1

0.40

363

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

662

1.29

1.48

1.5

1.6

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

186

1.56

1.48

1.3

1.2

mmol/l

2.3

2.1

0.19

174

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

323

2865

1.14

1.46

1.7

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

324

2875

1.14

1.45

3.6

3.9

ug/l

6.8

23.7

3.21

257

2357

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.37

1.45

1.4

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

285

1.44

1.45

2.7

1.8

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.12

1.44

1.4

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

569

5224

1.11

1.44

4.8

4.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

473

1.34

1.43

1.4

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

456

1.34

1.43

1.9

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

121

990

1.23

1.41

1.8

u/l

37.3

39.1

0.46

114

866

(44806118)

279

1.44

1.40

1.5

1.4

—

(44790048)

279

1.44

1.40

1.5

1.4

—

(44790047)

279

1.44

1.40

1.4

—

(44790049)

279

1.44

1.40

1.5

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

197

1.53

1.40

1.6

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

189

1.54

1.40

2.3

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

361

0.63

1.38

3.3

2.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.94

1.38

1.2

1.4

26.1

23.6

—

(3052592) Norovirus Ag [Presence] in Stool

2.00

1.38

1.1

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

228

1982

1.16

1.37

4.0

3.7

0.6

0.5

0.15

455

(3009445) Proteinase 3 Ab [Units/volume] in Serum

129

1068

1.22

1.36

1.4

1.5

u/ml

35.8

23.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

175

1.55

1.34

1.9

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.00

1.33

0.0

1.6

—

48.4

—

(4146454)

283

0.60

1.31

2.6

2.7

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

427

0.68

1.30

2.9

3.9

u/ml

15.9

34.7

3.41

417

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

292

1.41

1.30

1.3

1.4

pmol/l

314.8

321.3

0.04

224

(3045142) Bone marrow Pathology biopsy report

310

1.39

1.28

1.3

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

457

1.32

1.27

1.8

1.4

—

18.6

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

1.79

1.27

2.3

2.0

u/l

17.5

75.0

1.25

(3023199) Leukocytes [#/volume] in Pleural fluid

379

1.35

1.27

1.4

e6/l

2181.1

1671.3

0.47

269

(40758047) Lysozyme [Mass/volume] in Pleural fluid

2.29

1.26

1.0

1.3

mg/l

14.2

7.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

219

1.47

1.25

1.5

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

516

0.71

1.24

1.4

1.5

pmol/l

261.5

210.7

0.19

505

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

178

1532

1.17

1.24

1.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.40

1.24

1.3

1.8

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

190

0.52

1.24

1.1

—

72.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

672

1.26

1.23

5.1

3.1

—

(3028707) Methadone [Presence] in Urine by Screen method

237

1.44

1.22

2.7

2.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

296

1.39

1.22

1.1

u/ml

3.8

5.5

0.46

156

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.63

1.21

1.0

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

276

0.61

1.21

3.0

4.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

172

1.52

1.20

1.2

—

(3037756) Immunofixation for Serum or Plasma

604

1.26

1.18

1.9

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

132

1113

1.19

1.18

1.4

1.3

—

(3036603) Volume of Urine

173

1.51

1.17

1.3

1.4

1410.8

1813.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

472

1.30

1.17

4.2

4.8

iu/ml

759.6

741.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

127

0.47

1.16

2.0

2.4

—

(3024928) Oxygen saturation in Venous blood

597

1.26

1.16

2.6

2.9

—

(3025941) Bacteria identified in Stool by Culture

154

1320

1.17

1.15

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

166

1.51

1.14

1.3

mmol/l

11.1

11.8

0.27

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

102

844

1.22

1.12

1.8

1.6

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.34

1.12

1.0

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.71

1.11

1.1

—

(3008898) HLA-B27 [Presence]

655

1.24

1.11

1.1

—

(3011412) CD3 cells [#/volume] in Blood

209

1.44

1.10

3.1

2.2

e9/l

1.3

1.1

0.59

129

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

492

0.73

1.10

4.2

3.9

59.2

57.9

0.34

492

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

194

1700

1.15

1.10

4.0

4.1

kpa

5.1

5.2

0.27

177

1562

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

104

866

1.21

1.08

2.0

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

435

1.29

1.07

4.2

3.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

1.65

1.06

1.1

u/ml

0.3

1.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

533

1.26

1.06

1.1

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

105

1.62

1.06

9.0

9.9

mmol/l

0.6

0.03

(4268621)

229

1.40

1.03

2.3

2.4

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

289

1.35

1.03

1.7

1.9

—

3.1

—

(3000492) Spirometry study

241

2158

1.13

1.00

1.4

1.5

—

(21494434) Karyotype in Bone marrow

239

1.38

1.00

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

351

3210

1.10

1.00

1.4

—

(40758292) HTLV I+II Ab panel - Serum

2.00

1.00

1.4

1.3

—

(3032080) INR in Blood by Coagulation assay

1123

10764

1.07

0.99

8.8

10.1

inr

1.2

1.3

1.45

350

3013

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

206

1.41

0.98

5.6

4.9

u/ml

245.1

44.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.18

0.98

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

266

1.36

0.98

1.3

mosm/kgh2o

278.4

278.9

0.04

197

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

353

1.31

0.97

1.1

1.2

u/ml

1.6

3.1

0.93

116

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.95

0.97

13.6

15.2

mmol/l

4.5

5.6

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

100

1.60

0.96

3.3

1.9

umol/l

29.6

27.5

0.44

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.96

0.0

2.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

505

1.25

0.96

1.7

1.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.22

0.93

1.2

—

(40768806) Pleura Pathology biopsy report

312

1.32

0.93

1.6

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

490

1.25

0.92

2.3

2.1

u/l

3310.6

3353.7

0.01

196

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.73

0.92

4.1

2.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

384

1.28

0.91

1.1

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

627

1.22

0.90

1.2

titre

87.5

90.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.75

0.90

1.1

—

(3012516) Albumin [Mass/volume] in Urine

815

7759

1.07

0.88

3.4

3.3

mg/l

368.9

263.5

0.28

518

4957

(4094501)

639

1.21

0.87

1.1

—

(3045788) Cell count panel - Pleural fluid

298

1.31

0.87

1.5

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

0.87

1.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.00

0.87

1.5

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.00

0.87

1.5

1.1

105.7

96.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

326

1.29

0.85

1.1

1.2

124.7

115.1

0.99

294

(3022621) pH of Urine by Test strip

156

1763

0.88

0.85

3.0

3.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.63

0.84

1.2

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.94

0.84

1.5

1.2

u/ml

4.9

0.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.57

0.84

1.1

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

570

1.22

0.83

1.5

1.9

iu/l

3.4

4.5

0.58

187

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

262

2389

1.11

0.82

1.8

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

426

1.25

0.82

1.5

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

690

1.19

0.82

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.88

0.81

1.0

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

177

0.62

0.81

2.4

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

627

1.20

0.80

3.5

3.1

nmol/l

0.8

0.76

476

(3011648) Oxygen content in Venous blood

215

1.35

0.80

2.1

2.9

10.6

11.0

0.23

215

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

338

1.28

0.80

1.1

u/ml

0.7

1.7

1.00

138

(3016879) Cocaine [Presence] in Urine

491

1.23

0.80

2.0

2.1

—

(3051651) Icteric interference index of Serum or Plasma

164

1.41

0.79

4.5

3.7

—

(44806071)

0.00

0.79

0.0

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

159

1414

1.13

0.78

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.67

0.78

1.5

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.78

0.0

2.0

—

(4010399)

189

1699

1.12

0.78

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

260

1.31

0.78

1.0

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

676

1.19

0.77

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

124

0.56

0.77

1.4

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

124

0.56

0.77

1.4

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

269

1.30

0.77

1.1

u/ml

0.3

2.7

2.11

(3025130) Human papilloma virus identified in Specimen

234

1.33

0.77

1.4

1.8

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

233

0.69

0.76

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

313

0.73

0.75

1.2

1.1

—

(3042631) Mycobacterium sp identified in Specimen

347

0.75

2.8

2.9

—

(3010421) pH of Blood

711

0.83

0.74

7.6

4.2

7.4

0.23

581

(3003740) Influenza virus B Ag [Presence] in Specimen

312

0.74

0.73

1.2

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

133

0.60

0.73

1.8

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

133

0.60

0.73

1.8

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

133

0.60

0.73

1.8

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

133

0.60

0.73

1.8

1.5

—

(4035726)

254

2330

1.10

0.73

1.5

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

334

1.26

0.73

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

230

0.69

0.72

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

110

0.54

0.72

1.2

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

344

1.25

0.71

1.4

e6/l

266046.1

55605.6

1.06

204

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.58

0.71

1.0

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

1.58

0.71

1.2

1.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

1.51

0.69

1.1

1.5

14.5

19.2

0.28

(3005033) Fetal Nuchal fold Thickness US

228

0.70

0.69

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

230

1.31

0.69

2.0

1.9

—

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

409

0.78

0.69

1.4

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

611

1.18

0.69

1.7

1.9

mg/l

12.6

11.8

0.43

566

(44813793)

135

1.41

0.69

1.1

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

135

1.41

0.69

1.2

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.85

0.68

1.6

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

215

0.70

0.67

2.4

1.5

—

(44806420)

0.55

0.67

2.0

2.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

153

1.37

0.67

1.2

—

(3009343) pH of Capillary blood

185

1680

1.11

0.67

4.1

7.4

0.17

199

(3024869) Neuronal Ab [Presence] in Serum

1.63

0.66

1.3

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.54

0.65

1.0

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

689

1.17

0.65

1.9

1.7

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.59

0.65

1.3

5.0

umol/l

29.7

39.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1.59

0.65

1.6

2.8

—

70.3

—

(3029075) Extractable nuclear Ab panel - Serum

1.57

0.65

1.0

—

(3024932) HLA-DR beta [Type]

1.61

0.65

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

224

1.30

0.64

1.3

1.5

34.1

29.9

0.22

141

(3027944) Amphetamines [Presence] in Urine

523

1.19

0.64

2.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.73

0.64

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.73

0.64

1.8

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

359

1.23

0.64

1.7

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

342

1.23

0.62

1.2

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.63

0.62

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

130

1.39

0.61

3.8

4.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.60

0.0

1.4

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.60

0.0

1.0

—

(3022806) Fractional oxyhemoglobin in Capillary blood

344

0.78

0.59

4.1

1.7

89.5

89.3

0.08

339

(3048929) Epstein Barr virus Ab [Presence] in Serum

612

1.16

0.59

1.4

1.2

—

(1616796) Gas panel - Central venous blood

603

1.16

0.58

4.7

3.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

631

1.16

0.58

1.6

e6/l

8273.4

14053.2

1.51

439

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

538

1.17

0.58

1.8

1.5

—

(3024471) HLA-A [Type]

1.56

0.58

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

529

1.18

0.58

2.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.58

0.0

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.46

0.58

1.0

1.1

miu/ml

1901.1

1674.2

0.33

(4212803)

1.72

0.57

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

202

1.29

0.57

1.1

u/ml

5.9

2.6

0.25

(3051611) Lipemic interference index of Serum or Plasma

283

1.24

0.56

3.7

3.6

—

(3034426) Prothrombin time (PT)

1.51

0.56

1.1

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.62

0.55

1.5

1.6

ng/l

104.7

130.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

148

0.67

0.55

2.5

1.4

—

(3027008) Opiates [Presence] in Urine

533

1.17

0.54

2.0

—

(3006462) Nitrate [Presence] in Urine

124

0.64

0.54

6.9

3.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

142

1.34

0.54

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.49

0.53

1.2

114.1

109.4

0.33

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

177

1628

1.09

0.53

4.1

mmol/l

2.6

1.9

1.34

119

1204

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

405

1.19

0.52

1.5

1.2

u/ml

281.2

267.0

0.18

244

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.52

0.52

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

144

1577

0.91

0.52

1.3

1.4

—

(3028300) Cannabinoids [Presence] in Urine

536

1.16

0.51

2.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

161

1.31

0.51

1.8

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

100

0.60

0.51

1.8

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

100

0.60

0.51

1.8

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

100

0.60

0.51

1.8

1.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

630

1.15

0.51

1.4

1.2

u/ml

63.1

35.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

188

1.28

0.51

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

379

1.19

0.51

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.41

0.50

1.2

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

343

1.20

0.50

1.2

u/ml

3.1

3.7

0.19

153

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

264

2476

1.07

0.50

2.2

g/l

0.2

2.25

250

2300

(3001019) Free T4 and TSH panel - Serum or Plasma

934

0.89

0.49

1.7

—

(40768795) Lymph node Pathology biopsy report

234

1.24

0.49

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

399

1.18

0.49

1.3

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.49

7.1

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.49

7.1

2.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

154

1.30

0.48

1.2

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

253

1.23

0.48

1.2

u/l

75.5

57.0

1.33

178

(3014133) Dog dander IgE Ab [Units/volume] in Serum

226

1.24

0.48

1.1

1.0

u/ml

1.7

4.3

0.82

(3006653) Thiamine [Moles/volume] in Blood

128

1.33

0.47

1.0

1.2

nmol/l

148.2

140.4

0.19

128

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.47

0.47

1.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.41

0.46

1.1

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

245

1.23

0.46

1.4

1.5

nmol/l

0.3

0.14

187

(4024509)

236

1.23

0.46

1.7

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

740

1.12

0.46

1.4

iu/l

28.4

31.3

0.33

628

(3012501) Base excess in Blood by calculation

590

0.86

0.46

8.2

4.6

mmol/l

2.9

2.8

0.09

411

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.43

0.46

1.0

—

3.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

342

0.82

0.46

1.9

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

138

1.31

0.45

1.2

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

121

0.66

0.45

1.4

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

164

0.73

0.45

1.3

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.61

0.43

1.4

2.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

537

1.14

0.42

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

415

1.16

0.42

2.3

2.0

—

(3023383) Lactate [Moles/volume] in Pleural fluid

0.66

0.42

1.0

1.4

mmol/l

4.2

3.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

162

0.74

0.42

1.3

1.4

—

(3006598) pH of Arterial cord blood

1.56

0.42

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

1.56

0.42

1.0

—

-3.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.40

0.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

138

0.72

0.40

1.2

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

138

0.72

0.40

1.2

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

102

0.69

0.39

1.0

1.1

—

7.1

—

(40768800) Prostate Pathology biopsy report

588

1.12

0.39

1.1

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.43

0.39

1.0

1.3

nmol/l

3.7

303851.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.39

0.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

137

0.73

0.39

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

174

1627

1.07

0.39

1.4

—

(3021788) Differential panel - Synovial fluid

474

0.86

0.39

1.6

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

115

1.31

0.38

1.0

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

302

0.83

0.38

1.4

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

148

0.74

0.38

2.4

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

562

1.12

0.37

3.3

2.4

16.6

16.0

0.71

293

(3044941) Cell count panel - Synovial fluid

430

1.14

0.37

1.5

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.31

0.37

1.3

1.4

—

(3000285) Sodium [Moles/volume] in Blood

1.35

0.37

1.2

1.0

—

(40768793) Breast Pathology biopsy report

556

0.88

0.36

1.3

—

(3044927) Protein electrophoresis panel - Urine

278

0.83

0.36

1.3

1.2

—

(3028433) Virus identified in Specimen by Culture

0.65

0.35

1.0

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.63

0.35

1.0

—

(3017569) Oxygen content in Arterial blood

153

1.24

0.35

2.3

2.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

117

1.28

0.35

1.1

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

301

1.16

0.35

1.7

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

532

0.88

0.34

1.3

miu/ml

191.1

212.8

0.17

229

(3034274) Bile acid [Moles/volume] in Serum --fasting

181

1.22

0.34

2.5

2.2

umol/l

5.3

8.0

0.72

127

(40765089) Chromosome analysis panel - Blood by G-banded

1.36

0.34

1.0

—

(40768446) Kidney Pathology biopsy report

1.32

0.33

2.3

1.6

—

(4211845)

133

0.75

0.33

5.8

3.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

250

2381

1.05

0.33

2.2

2.4

ug/l

7.7

7.4

0.05

222

2063

(3010144) Erythrocytes [#/volume] in Synovial fluid

247

1.18

0.32

1.2

1.3

e6/l

10131.1

112812.4

1.49

169

(3001186) Copper [Moles/volume] in Serum or Plasma

1.28

0.32

2.3

1.3

umol/l

14.8

17.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.35

0.32

1.0

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

128

1.25

0.32

11.1

17.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

295

1.15

0.31

1.4

1.5

59.5

61.4

0.09

191

(3002619) Bacteria identified in Specimen by Culture

1.35

0.31

1.1

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

283

0.85

0.30

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

100

0.70

0.30

1.0

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

381

1.13

0.30

1.1

1.0

—

(4015189)

1.27

0.30

1.4

2.4

—

(3023419) Bacteria identified in Sputum by Culture

344

1.14

0.29

2.7

2.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

692

0.91

0.29

1.6

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

249

0.84

0.29

1.4

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

281

0.85

0.29

1.5

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

121

1.24

0.28

1.1

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

158

1.20

0.28

1.3

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.29

0.28

1.6

1.3

ug/l

8.2

9.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.30

0.28

1.1

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

386

0.88

0.28

1.8

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

280

0.86

0.28

1.5

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

186

1.18

0.28

1.1

1.0

ng/l

37.2

45.1

0.67

116

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

186

1.18

0.28

1.1

1.0

ng/l

274.4

310.9

0.48

120

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

186

1.18

0.28

1.1

1.0

ng/l

709.3

678.8

0.09

115

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

279

0.86

0.27

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

279

0.86

0.27

1.5

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

247

0.85

0.27

2.8

2.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

122

1.23

0.27

1.2

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

206

1.17

0.26

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

348

1.12

0.26

1.6

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

109

1023

1.07

0.25

4.0

3.2

u/ml

55.1

4998.0

1.11

874

(3050129) First trimester maternal screen panel - Serum or Plasma

351

0.88

0.25

1.5

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

1.25

0.24

1.1

1.2

u/ml

0.5

1.9

—

(3022313) Gas panel - Capillary blood

115

1218

0.94

0.24

4.1

4.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.19

0.21

1.0

3.5

—

75.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

3.0

—

(4038314)

0.00

0.21

0.0

1.3

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.21

0.0

1.3

—

(3024316) Viscosity of Plasma

0.00

0.21

0.0

1.3

—

1.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.24

0.21

1.0

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

272

0.88

0.20

1.4

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

145

1.17

0.20

1.0

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

2.2

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

17.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.20

0.0

1.0

—

(3047189) Immunofixation for 24 hour Urine

136

1.18

0.20

2.0

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

423

1.09

0.19

1.3

1.2

—

(3000330) Specific gravity of Urine by Test strip

137

1431

0.96

0.19

3.7

3.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

289

1.11

0.19

1.3

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

589

1.07

0.18

1.4

1.2

u/ml

13.7

7.5

0.34

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

194

1.13

0.18

1.0

u/ml

0.3

0.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

570

0.93

0.18

1.2

1.1

u/ml

0.8

6.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

638

1.07

0.18

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

147

1.16

0.18

1.0

1.3

—

(3017732) Neutrophils [#/volume] in Blood

168

1620

1.04

0.17

3.6

3.1

e9/l

3.8

4.1

0.87

138

1236

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.13

0.17

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.13

0.17

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.13

0.17

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.13

0.17

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.72

0.17

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

114

1091

1.05

0.16

3.7

5.0

1.9

1.6

1.05

109

1014

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.16

0.16

1.4

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.16

0.16

1.3

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

298

0.91

0.16

1.1

1.0

u/ml

1.3

2.1

—

111

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.14

0.16

1.1

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

177

1.13

0.16

1.2

1.4

promille

1.0

1.2

0.19

139

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

158

1.14

0.16

1.2

1.6

ug/l

1.8

4.9

1.13

133

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

183

0.87

0.16

1.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.79

0.15

1.3

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.21

0.15

1.2

1.3

47.5

61.2

—

(40765096) Chromosome analysis panel by Banding

1.14

0.15

1.0

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

159

1.13

0.15

1.2

1.1

nmol/l

8.7

10.1

—

(40768441) Liver Pathology biopsy report

169

1.12

0.14

1.2

1.4

—

(3010503) CD19 cells [#/volume] in Blood

139

0.86

0.14

2.5

2.1

e9/l

0.1

0.3

0.49

132

(3006576) Bicarbonate [Moles/volume] in Blood

1.19

0.14

12.6

6.8

mmol/l

24.6

24.7

—

(3000012) Reticulocyte production index

138

0.87

0.13

1.3

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

648

1.05

0.12

1.3

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

274

2798

0.98

0.12

3.9

3.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

433

1.06

0.12

1.7

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

488

0.94

0.12

1.5

1.7

nmol/l

0.8

0.09

407

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

702

0.95

0.12

1.3

1.6

iu/ml

0.0

9.4

0.59

146

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

763

0.96

0.12

1.3

1.6

mg/l

4.5

3.8

0.14

548

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

405

0.94

0.11

1.6

1.3

—

(3037121) Protein [Mass/volume] in Urine

873

0.96

0.11

3.8

3.4

g/l

0.4

0.3

0.11

358

(4281824)

260

1.08

0.10

1.0

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

584

1.05

0.10

1.3

1.2

u/ml

6.2

3.9

—

(1617658) Protocol used for examination of sentinel lymph nodes

197

0.91

0.09

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.09

0.09

1.4

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.09

0.09

1.2

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.15

0.09

2.1

2.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.04

0.09

2.2

2.8

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

116

1.12

0.09

17.1

11.9

nmol/l

997.5

816.3

0.48

111

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

268

0.93

0.09

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

253

2488

1.02

0.09

2.8

2.9

ng/l

165.6

239.8

3.00

236

2264

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

126

1.11

0.09

3.3

2.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.07

0.08

1.2

1.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

175

0.91

0.08

1.6

1.5

umol/l

14.1

13.3

0.14

167

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

302

1.06

0.08

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.82

0.08

2.4

1.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.83

0.08

1.2

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

0.81

0.08

1.8

1.9

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

111

1082

1.03

0.08

4.4

5.0

0.9

0.20

106

1008

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

117

1.11

0.08

1.0

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1.14

0.08

1.4

1.7

mmol/l

10.1

7.8

—

(3035637) Corticotropin [Mass/volume] in Plasma

283

1.06

0.08

1.7

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

598

1.04

0.08

1.7

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

127

1.10

0.08

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

727

1.03

0.07

4.9

4.1

—

(3048879) Bone marrow aspiration report

0.84

0.07

2.2

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

215

0.93

0.07

1.6

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

215

0.93

0.07

1.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

215

0.93

0.07

1.6

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.82

0.07

1.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

0.87

0.07

2.6

2.3

—

(3033799) Differential panel - Peritoneal fluid

1.06

0.07

1.3

1.8

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

558

0.97

0.06

2.5

3.3

u/ml

262.5

793.6

0.52

523

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

192

0.94

0.05

1.6

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

457

1.03

0.04

1.8

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

190

0.95

0.04

1.0

mg/l

282.2

290.8

0.26

169

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

230

0.96

0.03

2.1

1.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

379

1.03

0.03

1.1

iu/ml

26.1

76.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

211

1.04

0.03

1.1

—

(1761868) Lipid panel - Serum or Plasma

776

7738

1.00

0.02

2.8

3.0

—

(3004451) EKG impression Narrative

138

0.94

0.02

1.5

1.3

—

(3017704) Immunofixation for Urine

158

0.95

0.02

2.9

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

620

1.02

0.02

1.7

1.5

—

(3016228) CD19 cells/100 cells in Blood

1.08

0.02

2.1

10.7

9.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

143

1419

1.01

0.02

1.2

iu/ml

148.3

143.0

0.05

505

(3045683) HLA typing for celiac disease panel - Blood or Tissue

117

0.94

0.01

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

187

0.96

0.01

2.6

2.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

247

0.97

0.01

1.3

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

154

1.04

0.00

1.7

1.6

u/l

8.2

5.3

—

(3047181) Lactate [Moles/volume] in Blood

814

1.01

0.00

5.4

5.8

mmol/l

1.5

1.3

0.57

713

(3032773) Endomysium IgG Ab [Titer] in Serum

185

1.03

0.00

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

245

1.02

0.00

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

191

0.99

0.00

1.0

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

114

0.96

0.00

1.3

1.1

u/l

30.0

31.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

126

1.03

0.00

1.2

1.7

—

10.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

126

1.03

0.00

1.0

1.3

pmol/l

192.9

311.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

144

0.97

0.00

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

346

1.01

0.00

1.4

1.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

317

1.01

0.00

1.2

1.1

—

10.9

—

(3035880) pH of Pleural fluid

173

0.98

0.00

1.2

1.4

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.6

—

1962.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

5.3

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

1.0

—

4.4

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40757373) Influenza virus identified in Isolate

1.00

0.00

1.4

1.5

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.98

0.00

1.7

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.97

0.00

1.3

2.9

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.90

0.00

1.2

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

0.87

0.00

26.2

6.2

75.7

76.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.92

0.00

1.3

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.86

0.00

1.8

1.5

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.5

—

2.4

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

8.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.88

0.00

1.2

1.1

—

(3044007) Cell count panel - Peritoneal fluid

0.89

0.00

1.4

2.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

5.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

0.95

0.00

1.7

1.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

-0.00

0.0

1.4

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_HL_NAS and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_HL_NAS	1.051 [0.94, 1.18]	0.386
Birth year	0.994 [0.99, 1.0]	0.125

During the follow-up period (1.1.1998 — 31.12.2019), 3190 out of 11949 females with H8_HL_NAS died.

Males

Parameter	HR [95% CI]	p-value
H8_HL_NAS	1.146 [1.0, 1.31]	0.048
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 2866 out of 10220 males with H8_HL_NAS died.

Mortality risk

Mortality risk for people of age

years, who have H8_HL_NAS.

N-year risk	Females	Males
1	0.097%	0.217%
5	0.537%	1.333%
10	1.297%	3.267%
15	2.614%	6.252%
20	4.635%	10.136%

Relationships between endpoints

↥

Index endpoint: H8_HL_NAS – Other specified/unspecified hearing loss

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other specified/unspecified hearing loss

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints